Copyright Reports & Markets. All rights reserved.

Global Ultra-large Volume Wearable Injectors Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Ultra-large Volume Wearable Injectors

      • 1.1 Definition of Ultra-large Volume Wearable Injectors
      • 1.2 Ultra-large Volume Wearable Injectors Segment by Type
        • 1.2.1 Global Ultra-large Volume Wearable Injectors Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Electronical Injectors
        • 1.2.3 Mechanical Injectors
        • 1.2.4 Others
      • 1.3 Ultra-large Volume Wearable Injectors Segment by Applications
        • 1.3.1 Global Ultra-large Volume Wearable Injectors Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Cancer Treatment
        • 1.3.3 Auto-immune Treatment
        • 1.3.4 Blood Disorders Treatment
        • 1.3.5 Others
      • 1.4 Global Ultra-large Volume Wearable Injectors Overall Market
        • 1.4.1 Global Ultra-large Volume Wearable Injectors Revenue (2014-2025)
        • 1.4.2 Global Ultra-large Volume Wearable Injectors Production (2014-2025)
        • 1.4.3 North America Ultra-large Volume Wearable Injectors Status and Prospect (2014-2025)
        • 1.4.4 Europe Ultra-large Volume Wearable Injectors Status and Prospect (2014-2025)
        • 1.4.5 China Ultra-large Volume Wearable Injectors Status and Prospect (2014-2025)
        • 1.4.6 Japan Ultra-large Volume Wearable Injectors Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Ultra-large Volume Wearable Injectors Status and Prospect (2014-2025)
        • 1.4.8 India Ultra-large Volume Wearable Injectors Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Ultra-large Volume Wearable Injectors
      • 2.3 Manufacturing Process Analysis of Ultra-large Volume Wearable Injectors
      • 2.4 Industry Chain Structure of Ultra-large Volume Wearable Injectors

      3 Development and Manufacturing Plants Analysis of Ultra-large Volume Wearable Injectors

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Ultra-large Volume Wearable Injectors Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Ultra-large Volume Wearable Injectors
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Ultra-large Volume Wearable Injectors Production and Capacity Analysis
      • 4.2 Ultra-large Volume Wearable Injectors Revenue Analysis
      • 4.3 Ultra-large Volume Wearable Injectors Price Analysis
      • 4.4 Market Concentration Degree

      5 Ultra-large Volume Wearable Injectors Regional Market Analysis

      • 5.1 Ultra-large Volume Wearable Injectors Production by Regions
        • 5.1.1 Global Ultra-large Volume Wearable Injectors Production by Regions
        • 5.1.2 Global Ultra-large Volume Wearable Injectors Revenue by Regions
      • 5.2 Ultra-large Volume Wearable Injectors Consumption by Regions
      • 5.3 North America Ultra-large Volume Wearable Injectors Market Analysis
        • 5.3.1 North America Ultra-large Volume Wearable Injectors Production
        • 5.3.2 North America Ultra-large Volume Wearable Injectors Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Ultra-large Volume Wearable Injectors Import and Export
      • 5.4 Europe Ultra-large Volume Wearable Injectors Market Analysis
        • 5.4.1 Europe Ultra-large Volume Wearable Injectors Production
        • 5.4.2 Europe Ultra-large Volume Wearable Injectors Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Ultra-large Volume Wearable Injectors Import and Export
      • 5.5 China Ultra-large Volume Wearable Injectors Market Analysis
        • 5.5.1 China Ultra-large Volume Wearable Injectors Production
        • 5.5.2 China Ultra-large Volume Wearable Injectors Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Ultra-large Volume Wearable Injectors Import and Export
      • 5.6 Japan Ultra-large Volume Wearable Injectors Market Analysis
        • 5.6.1 Japan Ultra-large Volume Wearable Injectors Production
        • 5.6.2 Japan Ultra-large Volume Wearable Injectors Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Ultra-large Volume Wearable Injectors Import and Export
      • 5.7 Southeast Asia Ultra-large Volume Wearable Injectors Market Analysis
        • 5.7.1 Southeast Asia Ultra-large Volume Wearable Injectors Production
        • 5.7.2 Southeast Asia Ultra-large Volume Wearable Injectors Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Ultra-large Volume Wearable Injectors Import and Export
      • 5.8 India Ultra-large Volume Wearable Injectors Market Analysis
        • 5.8.1 India Ultra-large Volume Wearable Injectors Production
        • 5.8.2 India Ultra-large Volume Wearable Injectors Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Ultra-large Volume Wearable Injectors Import and Export

      6 Ultra-large Volume Wearable Injectors Segment Market Analysis (by Type)

      • 6.1 Global Ultra-large Volume Wearable Injectors Production by Type
      • 6.2 Global Ultra-large Volume Wearable Injectors Revenue by Type
      • 6.3 Ultra-large Volume Wearable Injectors Price by Type

      7 Ultra-large Volume Wearable Injectors Segment Market Analysis (by Application)

      • 7.1 Global Ultra-large Volume Wearable Injectors Consumption by Application
      • 7.2 Global Ultra-large Volume Wearable Injectors Consumption Market Share by Application (2014-2019)

      8 Ultra-large Volume Wearable Injectors Major Manufacturers Analysis

      • 8.1 West Pharmaceuticals
        • 8.1.1 West Pharmaceuticals Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.1.2 West Pharmaceuticals Product Introduction, Application and Specification
        • 8.1.3 West Pharmaceuticals Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Unilife Corporation
        • 8.2.1 Unilife Corporation Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.2.2 Unilife Corporation Product Introduction, Application and Specification
        • 8.2.3 Unilife Corporation Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 CeQur
        • 8.3.1 CeQur Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.3.2 CeQur Product Introduction, Application and Specification
        • 8.3.3 CeQur Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Sensile Medical AG
        • 8.4.1 Sensile Medical AG Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.4.2 Sensile Medical AG Product Introduction, Application and Specification
        • 8.4.3 Sensile Medical AG Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 BD Medical
        • 8.5.1 BD Medical Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.5.2 BD Medical Product Introduction, Application and Specification
        • 8.5.3 BD Medical Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Enable Injections
        • 8.6.1 Enable Injections Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.6.2 Enable Injections Product Introduction, Application and Specification
        • 8.6.3 Enable Injections Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Roche Laboratories
        • 8.7.1 Roche Laboratories Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.7.2 Roche Laboratories Product Introduction, Application and Specification
        • 8.7.3 Roche Laboratories Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 scPharmaceuticals
        • 8.8.1 scPharmaceuticals Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.8.2 scPharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 scPharmaceuticals Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 SteadyMed Therapeutics
        • 8.9.1 SteadyMed Therapeutics Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.9.2 SteadyMed Therapeutics Product Introduction, Application and Specification
        • 8.9.3 SteadyMed Therapeutics Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Johnson & Johnson
        • 8.10.1 Johnson & Johnson Ultra-large Volume Wearable Injectors Production Sites and Area Served
        • 8.10.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.10.3 Johnson & Johnson Ultra-large Volume Wearable Injectors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Ultra-large Volume Wearable Injectors Market

      • 9.1 Global Ultra-large Volume Wearable Injectors Market Trend Analysis
        • 9.1.1 Global Ultra-large Volume Wearable Injectors Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Ultra-large Volume Wearable Injectors Regional Market Trend
        • 9.2.1 North America Ultra-large Volume Wearable Injectors Forecast 2019-2025
        • 9.2.2 Europe Ultra-large Volume Wearable Injectors Forecast 2019-2025
        • 9.2.3 China Ultra-large Volume Wearable Injectors Forecast 2019-2025
        • 9.2.4 Japan Ultra-large Volume Wearable Injectors Forecast 2019-2025
        • 9.2.5 Southeast Asia Ultra-large Volume Wearable Injectors Forecast 2019-2025
        • 9.2.6 India Ultra-large Volume Wearable Injectors Forecast 2019-2025
      • 9.3 Ultra-large Volume Wearable Injectors Market Trend (Product Type)
      • 9.4 Ultra-large Volume Wearable Injectors Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Ultra-large Volume Wearable Injectors Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Ultra-large volume wearable injectors are a new innovation within the injectable drug delivery market. These injectors are used to deliver large (>1-2 mL) volumes of drugs to drug developers, clinicians, and patients.

        The global Ultra-large Volume Wearable Injectors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Ultra-large Volume Wearable Injectors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ultra-large Volume Wearable Injectors market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Ultra-large Volume Wearable Injectors in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Ultra-large Volume Wearable Injectors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        West Pharmaceuticals
        Unilife Corporation
        CeQur
        Sensile Medical AG
        BD Medical
        Enable Injections
        Roche Laboratories
        scPharmaceuticals
        SteadyMed Therapeutics
        Johnson & Johnson

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Electronical Injectors
        Mechanical Injectors
        Others

        Segment by Application
        Cancer Treatment
        Auto-immune Treatment
        Blood Disorders Treatment
        Others

        Buy now